At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 40 enrolled

Drug / intervention

0.1% triamcinolone CREAM +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02680301

NCT02680301Phase 4Completed

Compare CT.gov

Comparing Efficacy of Topical Steroid Cream vs. Ointment Formulations Using Wet Dressings for Treatment of Atopic Dermatitis

Seton Healthcare Family·interventional·Posted Feb 11, 2016·Updated Jun 18, 2019

In Brief

A Phase 4 clinical trial evaluating 0.1% triamcinolone CREAM and 0.1% triamcinolone OINTMENT for Dermatitis, Atopic. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is to 1. Compare efficacy of 0.1% triamcinolone containing wet wrap as an ointment or as a cream formulation in patients with moderate to severe atopic dermatitis 2. The relative patient/subject acceptance and adherence will also be compared between the two wet wrap types

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDermatitis, Atopic

CountriesUnited States

Collaborators--

Timeline

Phase 4CompletedFinished

20162017201820192020202120222023202420252026

First PostedFeb 2016

Enrollment StartMar 2016

Primary CompletionMar 2017

Study CompletionJun 2018

TodayJul 2026

First PostedFeb 11, 2016

Enrollment StartMar 1, 2016

Primary CompletionMar 1, 2017

Study CompletionJun 1, 2018

TodayJul 2, 2026

Enrollment to primary: 1 yearPosted 10.4 years ago

Interventions

0.1% triamcinolone CREAMdrug

Patients will be asked to apply a topical steroid in a cream formulation to one extremity using the wet wrap technique.

0.1% triamcinolone OINTMENTdrug

Patients will be asked to apply a topical steroid in a ointment formulation to one extremity using the wet wrap technique.